Clinical features and treatment of intracranial chordoid meningioma: A report of 30 cases

Histopathology

Volumn 62, Issue 7, 2013, Pages 1002-1017

  Wang, Xiao Qiang ^a   Mei, Guang Hai ^a   Zhao, Lin ^a   Li, Shi Ting ^b   Gong, Ye ^a   Zhong, Jun ^b   Chen, Hong ^a   Jiang, Cheng Chuan ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Brain tumor; Chordoid meningioma; Intracranial; MIB 1; Prognosis

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OBSERVATION; FEMALE; GAMMA KNIFE RADIOSURGERY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL CHORDOID MENINGIOMA; MALE; MENINGIOMA; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BRAIN; CHINA; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOTOCHORD; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE; YOUNG ADULT;

EID: 84877879284     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12113     Document Type: Article

References (46)

1. Mawrin C, Perry A. Pathological classification and molecular genetics of meningiomas. J. Neurooncol. 2010; 99; 379-391.
2. Kozler P, Benes V, Netuka D, Kramar F, Hrabal P, Charvat F. Chordoid meningioma: presentation of two case reports, review of the literature, and plea for data standardisation. J. Neurooncol. 2008; 88; 115-120.
3. Louis DN, Ohgaki H, Wiestler OD, etal. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114: 97-109.
4. Kepes JJ, Chen WY, Connors MH, Vogel FS. 'Chordoid' meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome. A report of seven cases. Cancer 1988; 62; 391-406.
5. Tena-Suck ML, Collado-Ortiz MA, Salinas-Lara C, Garcia-Lopez R, Gelista N, Rembao-Bojorquez D. Chordoid meningioma: a report of ten cases. J. Neurooncol. 2010; 99; 41-48.
6. Lin JW, Ho JT, Lin YJ, Wu YT. Chordoid meningioma: a clinicopathologic study of 11 cases at a single institution. J. Neurooncol. 2010; 100; 465-473.
7. Lui PC, Chau TK, Wong SS etal. Cytology of chordoid meningioma: a series of five cases with emphasis on differential diagnoses. J. Clin. Pathol. 2007; 60; 1024-1028.
8. Epari S, Sharma MC, Sarkar C, Garg A, Gupta A, Mehta VS. Chordoid meningioma, an uncommon variant of meningioma: a clinicopathologic study of 12 cases. J. Neurooncol. 2006; 78; 263-269.
9. Couce ME, Aker FV, Scheithauer BW. Chordoid meningioma: a clinicopathologic study of 42 cases. Am. J. Surg. Pathol. 2000; 24; 899-905.
10. Kobata H, Kondo A, Iwasaki K, Kusaka H, Ito H, Sawada S. Chordoid meningioma in a child. Case report. J. Neurosurg. 1998; 88; 319-323.
11. Sangoi AR, Dulai MS, Beck AH, Brat DJ, Vogel H. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation. Am. J. Surg. Pathol. 2009; 33; 669-681.
12. Lee DK, Kim DG, Choe G, Chi JG, Jung HW. Chordoid meningioma with polyclonal gammopathy. Case report. J. Neurosurg. 2001; 94; 122-126.
13. Mori S, Oka K, Hakozaki H, etal. Chordoid meningioma. A case report. Pathol. Res. Pract. 2001; 197; 515-518; discussion 519.
14. de TO Jr, Herculano MA, Prandini MN, Stavile JN, Bonatelli AP. Chordoid meningioma: report of two cases. Arq. Neuropsiquiatr. 2003; 61; 91-94.
15. Ibrahim A, Galloway M, Leung C, Revesz T, Crockard A. Cervical spine chordoid meningioma. Case report. J. Neurosurg. Spine 2005; 2; 195-198.
16. Arima T, Natsume A, Hatano Het al. Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6. Case report. J. Neurosurg. 2005; 102; 733-737.
17. Denaro L, Di Rocco F. Di Gessi M et al. Pyrogenic cytokine interleukin-6 expression by a chordoid meningioma in an adult with a systemic inflammatory syndrome. Case report and review of the literature. J. Neurosurg. 2005; 103; 555-558.
18. McIver JI, Scheithauer BW, Atkinson JL. Deep Sylvian fissure chordoid meningioma: case report. Neurosurgery 2005; 57; E1064.
19. Takei H, Rivera A, Suzuki H, Bahrami A, Powell SZ. Jugular foramen chordoid meningioma. Pathol. Int. 2006; 56; 397-401.
20. Song KS, Park SH, Cho BK, Wang KC, Phi JH, Kim SK. Third ventricular chordoid meningioma in a child. J. Neurosurg. Pediatr. 2008; 2; 269-272.
21. Scott A, Sharkawi E, Micallef C, Johns P, Grant L. Chordoid meningioma presenting as painful orbital apex syndrome in pregnancy. Int. Ophthalmol. 2008; 28; 355-357.
22. Wilson JL, Ellis TL, Mott RT. Chordoid meningioma of the third ventricle: a case report and review of the literature. Clin. Neuropathol. 2011; 30; 70-74.
23. Petscavage JM, Richardson ML, Nett M, Hoch B. Primary chordoid meningioma of the lung. J. Thorac. Imaging 2011; 26; W14-W16.
24. Malloy KA, Chigbu DI. Anterior temporal chordoid meningioma causing compressive optic neuropathy. Optom. Vis. Sci. 2011; 88; 645-651.
25. Cassereau J, Lavigne C, Michalak-Provost S, Ghali A, Dubas F, Fournier HD. An intraventricular clear cell meningioma revealed by an inflammatory syndrome in a male adult: a case report. Clin. Neurol. Neurosurg. 2008; 110; 743-746.
26. Takei H, Bhattacharjee MB, Adesina AM. Chordoid glioma of the third ventricle: report of a case with cytologic features and utility during intraoperative consultation. Acta Cytol. 2006; 50; 691-696.
27. Park SC, Oh DE, Suh YL, Kim YD. Orbital chordoid meningioma: a rare subtype of meningioma. Ophthal. Plast. Reconstr. Surg. 2007; 23; 246-248.
28. Chen H, Li XM, Chen YC, etal. Intracranial clear cell meningioma: a clinicopathologic study of 15 cases. Acta. Neurochir. (Wien). 2011; 153; 1769-1780.
29. Cho HY, Lee M, Takei H, Dancer J, Ro JY, Zhai QJ. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma. Appl. Immunohistochem. Mol. Morphol. 2009; 17; 131-138.
30. Bo L, Mork SJ, Nyland H. An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol. Appl. Neurobiol. 1992; 18; 548-558.
31. Zeltner L, Schittenhelm J, Mittelbronn M etal. The astrocytic response towards invasive meningiomas. Neuropathol. Appl. Neurobiol. 2007; 33; 163-168.
32. Weber DC, Lovblad KO, Rogers L. New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr. Opin. Neurol. 2010; 23; 563-570.
33. Vranic A, Popovic M, Cor A, Prestor B, Pizem J. Mitotic count, brain invasion, and location are independent predictors of recurrence-free survival in primary atypical and malignant meningiomas: a study of 86 patients. Neurosurgery 2010; 67; 1124-1132.
34. Perry A, Louis D, Scheithauer B, et al. Meningiomas. In Health W ed. Organization Classification of Tumours of the Central Nervous System. 4th ed. Lyon: IARC Press, 2007; 164-172.
35. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC. 'Malignancy' in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 1999; 85; 2046-2056.
36. Willis J, Smith C, Ironside JW, Erridge S, Whittle IR, Everington D. The accuracy of meningioma grading: a 10-year retrospective audit. Neuropathol. Appl. Neurobiol. 2005; 31; 141-149.
37. Cattoretti G, Becker MH, Key G etal. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J. Pathol. 1992; 168; 357-363.
38. Key G, Becker MH, Baron B etal. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope. Lab. Invest. 1993; 68; 629-636.
39. Bruna J, Brell M, Ferrer I, Gimenez-Bonafe P, Tortosa A. Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 2007; 27; 114-120.
40. Hsu DW, Efird JT, Hedley-Whyte ET. MIB-1 (Ki-67) index and transforming growth factor-alpha (TGF alpha) immunoreactivity are significant prognostic predictors for meningiomas. Neuropathol. Appl. Neurobiol. 1998; 24; 441-452.
41. Yamasaki F, Yoshioka H, Hama S, Sugiyama K, Arita K, Kurisu K. Recurrence of meningiomas. Cancer 2000; 89: 1102-1110.
42. Ho DM, Hsu CY, Ting LT, Chiang H. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer 2002; 94; 1538-1547.
43. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 1998; 82; 2262-2269.
44. Campbell BA, Jhamb A, Maguire JA, Toyota B, Ma R. Meningiomas in 2009: controversies and future challenges. Am. J. Clin. Oncol. 2009; 32; 73-85.
45. Abramovich CM, Prayson RA. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome. Am. J. Clin. Pathol. 2000; 114; 84-92.
46. Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J. Neurooncol. 2010; 99; 433-443.